We are live on ! Find out more
O

Ossiam Portfolio holdings

AUM $5.69B
1-Year Est. Return 30.95%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+30.95%
3 Year Est. Return
+104.81%
5 Year Est. Return
+127.55%
10 Year Est. Return
AUM
$3.86B
AUM Growth
+$405M
Cap. Flow
+$318M
Cap. Flow %
8.23%
Top 10 Hldgs %
30.09%
Holding
728
New
12
Increased
230
Reduced
248
Closed
17

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$118M
2
AAPL icon
Apple
AAPL
+$88.5M
3
NFLX icon
Netflix
NFLX
+$47M
4
PEP icon
PepsiCo
PEP
+$30M
5
MCD icon
McDonald's
MCD
+$29.8M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$73.3M
2
STLA icon
Stellantis
STLA
+$27.4M
3
UNH icon
UnitedHealth
UNH
+$23.4M
4
ABBV icon
AbbVie
ABBV
+$20.9M
5
PNC icon
PNC Financial Services
PNC
+$19M

Sector Composition

Rank Sector Weight
1 Technology 26.72%
2 Consumer Discretionary 18.71%
3 Financials 18.25%
4 Communication Services 12.32%
5 Healthcare 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMUS icon
26
T-Mobile US
TMUS
$193B
$39.1M 1.01%
278,939
-2,421
-0.9% -$348K
CDNS icon
27
Cadence Design Systems
CDNS
$90B
$38.5M 1%
239,533
-3,200
-1% -$512K
PEP icon
28
PepsiCo
PEP
$186B
$36.8M 0.95%
203,697
+168,053
+471% +$30M
JPM icon
29
JPMorgan Chase
JPM
$939B
$36.1M 0.94%
269,032
+23,866
+10% +$3.02M
V icon
30
Visa
V
$677B
$33.4M 0.87%
160,867
+8,197
+5% +$1.65M
ECL icon
31
Ecolab
ECL
$75.6B
$32.8M 0.85%
225,111
+15,009
+7% +$2.21M
TMO icon
32
Thermo Fisher Scientific
TMO
$211B
$32.7M 0.85%
59,311
+20,101
+51% +$10.7M
PFE icon
33
Pfizer
PFE
$140B
$31.7M 0.82%
617,970
+467,257
+310% +$22.4M
XOM icon
34
ExxonMobil
XOM
$651B
$30.4M 0.79%
275,896
+84,655
+44% +$9.07M
C icon
35
Citigroup
C
$222B
$30M 0.78%
662,573
+190,626
+40% +$8.66M
FMC icon
36
FMC
FMC
$1.42B
$29.6M 0.77%
236,914
-8,355
-3% -$1.02M
LIN icon
37
Linde
LIN
$237B
$29.4M 0.76%
90,020
-34,047
-27% -$10.7M
NEM icon
38
Newmont
NEM
$98.2B
$28.8M 0.75%
609,649
-7,842
-1% -$350K
FISV
39
Fiserv Inc
FISV
$27.2B
$28.3M 0.73%
279,861
-7,684
-3% -$765K
KO icon
40
Coca-Cola
KO
$354B
$28.3M 0.73%
444,668
+166,206
+60% +$10M
VRTX icon
41
Vertex Pharmaceuticals
VRTX
$121B
$27.7M 0.72%
96,059
+1,765
+2% +$538K
LLY icon
42
Eli Lilly
LLY
$1.07T
$26.5M 0.69%
72,476
+65,696
+969% +$23.3M
DD icon
43
DuPont de Nemours
DD
$18.6B
$25M 0.65%
289,799
-12,911
-4% -$1.03M
IFF icon
44
International Flavors & Fragrances
IFF
$19.4B
$24.6M 0.64%
234,603
+23,881
+11% +$2.35M
AZO icon
45
AutoZone
AZO
$48.3B
$23.6M 0.61%
9,553
+1,782
+23% +$4.31M
AMCR icon
46
Amcor
AMCR
$20.6B
$23.1M 0.6%
388,734
+29,065
+8% +$1.69M
MCO icon
47
Moody's
MCO
$81.7B
$22.6M 0.59%
81,239
+11,695
+17% +$3.2M
ON icon
48
ON Semiconductor
ON
$33.8B
$21.8M 0.57%
349,920
-28,008
-7% -$1.87M
GS icon
49
Goldman Sachs
GS
$313B
$21.7M 0.56%
63,193
-7,572
-11% -$2.64M
VRSN icon
50
VeriSign
VRSN
$25.3B
$20.5M 0.53%
99,717
-1,292
-1% -$248K

Similar funds

Ossiam's Q4 2022 Portfolio in Review

As of Q4 2022, Ossiam held 728 positions worth $3.86B, up 12% from $3.45B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ossiam deployed $318M of net new capital in Q4 2022, opening 12 new positions and adding to 230 existing holdings. Its largest new stake was First Solar: 11,730 shares worth $1.76M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $73.3M trimmed.

  • Ossiam's largest Q4 2022 buy was First Solar: 11,730 shares worth $1.76M.
  • Ossiam added most to Amazon in Q4 2022, an estimated $118M increase.
  • Ossiam's biggest Q4 2022 reduction was Microsoft, cutting an estimated $73.3M.
  • Ossiam fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.91M.
  • Ossiam's ten largest holdings make up 30% of its $3.86B portfolio in Q4 2022.
  • Ossiam opened 12 new positions and closed 17 in Q4 2022.
  • Ossiam's portfolio value rose 12% quarter-over-quarter to $3.86B.

Based on Ossiam's 13F filing for Q4 2022, filed 13 Feb 2023.